Skip to main content

ETH Zurich Licenses DNAStar's Lasergene for Sequence Analysis


DNAStar said this week that the Swiss Federal Institute of Technology, or ETH, Zurich has selected its Lasergene software for sequence analysis.

The financial terms of the license agreement were not disclosed.

The Lasergene DNA and protein sequence analysis software is comprised of eight applications including tools for sequence assembly and SNP detection, automated virtual cloning, and primer design.

Other institutions that have licensed the product for their genomic analysis projects this year include Monash University (BI 12/2/2011) and the University of Texas (BI 11/11/2011).

The ETH Zurich agreement is the first European deal disclosed since the company this summer terminated a 15-year agreement that authorized GATC Biotech to distribute Lasergene in several European countries, opting instead to market its products directly to customers in those markets (BI 7/22/2011).

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.